Search

Blog

We constantly analyse the legislation and regulatory information related to a specific medicine in order to appraise the context in which the company operates

We put all our knowledge into play to anticipate risks and seize every opportunity, but above all to understand the rules of the game and display our creativity with them. We spread material and information proceeding from our investigation into medicines governance and regulatory science. In fact, we deem it necessary to be aware of the complexity of the results of research, regulation and drug policy in order to be able to work in a cultural ecosystem aiming both at promoting research outcomes that are useful to patients and at encouraging politicians to protect people’s health. The wider the knowledge of each interest group, the greater their ability to interact and achieve transparency of procedures and health protection.

  • All
  • Scenario analysis
  • Notes
  • Drug Policy
  • Rare Diseases
  • Mapping
  • Team Pharma Value
All
  • All
  • Scenario analysis
  • Notes
  • Drug Policy
  • Rare Diseases
  • Mapping
  • Team Pharma Value
GIRF Bologna

Pharma Value at the 3rd GIRF Congress - ISPOR Group Rome for Future

On 19 and 20 June, the 3rd National Congress of the Ispor Roma for Future GIRF group was held in Bologna, confirming ...
Read more "
Aifa Guidelines - Pharma Value comments

Technical Table for the revision of AIFA Notes and Therapeutic Plans

Update 17 June 2024 Below are the appointments updated to 17 June 2024. On the AIFA website you can read the new determination ...
Read more "

New AIFA special: CSE and reorganisation

The series of Nomos and Pharma Value specials regarding the governance of the Medicine and its Agency continues. After the seven extensions ...
Read more "

LEA 2024 Commission

The National Commission for Updating the Essential Levels of Care (LEA) was renewed by Ministerial Decree of 18/03/2024. The President of the Commission ...
Read more "

Happy Easter from #TeamPharmaValue

Our Easter greeting this year is multi-voiced. Each person in the team wanted to share their thoughts on Easter, ...
Read more "

Pharma Value_1 year from SRL

A year has already passed since 17 February 2023, when, defying superstition and low immune defences, Pharma Value decided to grow, ...
Read more "

Just be patient

On 14 February 2024 in Rome, at the Capranichetta Hall of the Hotel Nazionale, the presentation of 'Basta essere Pazienti', a campaign by the ...
Read more "

New AIFA Special Update: CSE and REORGANISATION

Update 1 March 2024 Below is the updated document with appointments and update timeline to 1 March 2024. Original text Pharma Value has ...
Read more "
negotiating orphan drugs

The Orphan Drug Comparator: a survey to identify challenges in price negotiations with AIFA

In collaboration with Rarelab, we launched a survey with the aim of assessing the actual impact of the use of comparators in the negotiation of orphan drugs, ...
Read more "
en_GB